Endocrine System Channel
Related Channels

Generic Rosiglitazone and Glimepiride

When Will Generic Rosiglitazone and Glimepiride Be Available?

The first patent for rosiglitazone and glimepiride expired in 2012. However, no generic versions are available yet. This suggests that one or more later-expiring patents are still protecting the drug from generic competition. The next patent for this medication is set to expire in October 2015.


However, there are other circumstances that could come up to extend the exclusivity period of rosiglitazone and glimepiride beyond 2015. This could include such things as other patents for specific uses of the drug or lawsuits. Once rosiglitazone and glimepiride goes off patent, there may be several companies that manufacture a generic version of the drug.

What If My Insurance Won't Cover Rosiglitazone and Glimepiride?

Some insurance companies that do not cover the drug may cover the two medications in rosiglitazone and glimepiride separately. In other words, even if rosiglitazone and glimepiride is not covered, you may have coverage for Avandia (rosiglitazone) and glimepiride (Amaryl). You would need two separate prescriptions from your healthcare provider, and you would likely need to pay two co-pays. For some people, this option may be more cost effective, although it would result in needing to take more tablets per day.
Type 2 Diabetes: Fact or Fiction
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.